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Usually the genetics of human longevity is restricted to the nuclear genome (nDNA). However it is well known that the nDNA
interacts with a physically and functionally separated genome, the mitochondrial DNA (mtDNA) that, even if limited in length
and number of genes encoded, plays a major role in the ageing process. The complex interplay between nDNA/mtDNA and the
environment is most likely involved in phenomena such as ageing and longevity. To this scenario we have to add another level
of complexity represented by the microbiota, that is, the whole set of bacteria present in the different part of our body with their
whole set of genes. In particular, several studies investigated the role of gut microbiota (GM) modifications in ageing and longevity
and an age-related GM signature was found. In this view, human being must be considered as “metaorganism” and a more holistic
approach is necessary to grasp the complex dynamics of the interaction between the environment and nDNA-mtDNA-GM of the
host during ageing. In this review, the relationship between the three genetics and human longevity is addressed to point out that
a comprehensive view will allow the researchers to properly address the complex interactions that occur during human lifespan.
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1. Introduction
Longevity is a complex trait whose genetics has been exten-
sively studied since many years. Understanding the genetic
makeup that predisposes to longevity is an urgent challenge
owing to the explosion of the elder population in western as
well as in emerging countries.
Usually the studies on the genetics of human longevity are
restricted to the analysis of nuclear genome (nDNA). How-
ever, another essential genome, that is, the mitochondrial
genome (mtDNA), is part of the genetic machinery of each
cell. Despite its limited length, the mtDNA encodes for few
genes that constitute a quantitatively relevant group because
of the high copy number of mtDNA in each cell.
These two genomes do not work in the void and
life/survival, as well as ageing and longevity, depends on
their complex interaction with environment/lifestyle. To this
scenario we have to add another level of genetic complexity
represented by the microbiota, that is, the whole set of
bacteria that live in different anatomical districts of our body
with their whole set of genes (microbiome). Indeed, the
most comprehensive view is to consider human being as a
“metaorganism” resulting from the close relationship with
symbiont microbial ecosystems. A particular attention has
been recently devoted to the gut microbiome (GM). The GM
probably represents the most adaptable genetic counterpart
of the human metaorganisms, being extremely plastic in
response to age-related physiological changes in diet and
modification in lifestyle.
Thus, the result of the ageing process is defined by the
sum of a number of factors both biological and nonbiological
(environmental and stochastic). Therefore while the ageing
research based on the study of animalmodels starts assuming
the existence of major genes that determine longevity, in
humans this assumption represents an oversimplification.
The study of human model imposes a more holistic view of
the genetics to grasp the complex dynamics of the interaction
between the environment, stochasticity, and the three genet-
ics of the host (nDNA, mtDNA, and GM).
The main aim of this review is to sum up the state-of-
the-art of the knowledge of the three genetic components
in human longevity to demonstrate that within this compre-
hensive view the genetics moves from a crystallized concept
(genes are forever) to a much more flexible and dynamic per-
spective, in which the complex interaction between genetic
makeup and environment across the long-lasting human
lifespan is properly addressed.
2. The Nuclear Genome
The study of genetics of ageing in human being is tan-
gled given the high complexity of the interaction between
heterogeneous environmental factors and genetic variability
across a long period of time. A strategy for disentangling this
complexity is to focus on robust human models of longevity
such as centenarians.
Centenarians are a model of successful ageing as in
most cases they display medical histories free from most of
the major age-related diseases, including cancer, demen-
tia, diabetes, and cardiovascular diseases. Their ability to
reach the extreme limit of human life—escaping, or largely
postponing, age-associated pathologies—is the result of the
combination of a well-preserved and efficient immune sys-
tem, a good capability to cope with different stressors, an
appropriate lifestyle, and a robust genetic background [1–5].
At the beginning, studies on longevity were conducted
on lower organisms and animal models, providing evidences
that longevity could be influenced bymany conserved genetic
variants with small effects [6]. Complying with this idea,
several association studies have been conducted, comparing
centenarians’ genetic profile to that of younger cohorts.
Several gene variants have been found to be associated with
longevity, including IL6 -174 C/G [7], IL10 -1082 A/G [8, 9],
PON1 gene [10], SOD2 401nt T/C [11], the arginine to proline
amino acid substitution inTP53 gene at codon 72 [12–15], and
insulin/IGF1 signal response pathway [16–21], but replication
studies have provided contradictory results [22].
This can be due to different reasons that include the effect
of population structure [23] and the lack of an appropriate
control group [24]. The best control group for centenarians
should include subjects born in the same birth cohort
since younger subjects could be grown up in very different
environmental and socioeconomic conditions. Furthermore,
the recruitment of an elderly cohort until the age of 100
is demanding also from the “experimental” point of view.
Considering that in Italy 1/4000 individuals is centenarian,
to perform a study with 100 centenarians researchers should
consider a pool of about 400000 people and a much larger
cohort to perform a longitudinal study with a final cohort
of a hundred of survivors over 100 years of age [25]. This
calculation clearly explains the difficulties in carrying out
longitudinal studies on human longevity that include the
extreme decades of life.
Technological advances in the last 10 years have fostered
the study of the genetics of complex traits by means of
genome-wide approaches that allow the simultaneous anal-
ysis of thousands of genetic variants on large cohorts.
Many genome-wide association studies (GWASs) have
been conducted assuming that long-lived individuals could
share several common genetic variants that influence human
lifespan.
Nebel et al. genotyped 1848 Germans, 763 individuals
aged 94–110 years and 1085 controls aged 45–77 years, and
replicated the results on an independent cohort of 1614
subjects. They reported a statistical significant association
only for one SNP, rs4420638, that is located near APOC1 and
is in linkage with APOE [26].
Deelen et al. [27] compared 403 unrelated nonagenarians
and 1670 younger controls from the Leiden Longevity Study
cohort and tested the emerged SNPs on 4149 nonagenarians
and 7582 controls from the Rotterdam Study, Leiden 85-plus
study, and Danish 1905 cohort. Only rs2075650 is associated
with survival to old age also in the replication stage (OR =
0.71, 95%CI = 0.65–0.77, and 𝑃 = 3.39 ∗ 10−17). This
SNP is located in TOMM40 gene, close to APOE gene and,
even if it displays only a moderate linkage with APOE 𝜀4
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determining variant, authors report an APOE dependent
effect of rs2075650 on longevity.
Another GWAS was performed by Sebastiani et al. [28]
considering initially 801 long-lived individuals (95–119 yrs)
and 914matched controls from theNewEnglandCentenarian
Study. They identified 281 SNPs (about 130 genes) that they
used to build a genetic risk model to distinguish cases (long-
lived) from controls with 89% sensitivity/specificity. It is
interesting to note that about 50% of the SNPs included in
the model are located in intergenic regions, underlining that
the regulatory machine plays a major role in longevity. This
model has been tested in two independent cohorts (253 cen-
tenarians + 341 controls and 60 centenarians + 2863 controls)
providing results that are less exciting than those obtained
from the training datasets (60–58% and 78–61% sensitiv-
ity/specificity, resp.). Overfitting problems are commonwhen
high-dimensional data are managed and may play a role also
in the relatively poor accuracy reported for the proposed
model on the test datasets. Furthermore, authors reported
that sensitivity of the predictor increases with increasing age,
supporting the hypothesis that the influence of genetics on
longevity gets stronger with increasing age. Moreover, this
approach showed that different genetic signatures can be
used to group centenarians into different “longevity classes”
according to factors such as the prevalence or the age of onset
of age-related diseases [29]. Nevertheless, some centenarians
did not show a genetic signature of exceptional longevity, sug-
gesting that exceptional longevity might be better explained
by rare or private genetic variants. The 281 SNPs include
rs2075650 in TOMM40 gene but the contribution of this
variant to the predictive power of the genetic risk model is
poor. This is probably because of the low frequency of GG
genotype that is almost absent in centenarians (frequency:
0.1%) and that makes the prediction of lifespan of AG and
AA carriers uncertain without further genetic information
[28]. It is relevant to note that this particular SNP (rs2075650)
shows a cline in minor allele frequency from south to north
Europe and this stresses the importance of stratifying models
by ancestry.
Sebastiani and colleagues tested the 281 identified SNPs
on 5 studies of centenarians from USA, Europe, and Japan
and they found that 128 SNPs reached statistical significance,
bringing out biological pathways deeply involved in excep-
tional longevity [30].
APOE is the only gene accounted as a “longevity determi-
nant” by several independent GWASs. APOE𝜀 variants have
been extensively analyzed and the frequency of 𝜀4 allele has
been found decreased in long-lived subjects [31–33] but this
result varies among different populations [34, 35]. Recently,
Tan et al. proposed a method to identify the signature of
mortality deceleration at late age. They estimated the effect
of APOE𝜀4 variant in the Danish 1905 Birth Cohort and
they found that relative risk of 𝜀4 allele does not increase
linearly with age, supporting the idea that this allele exerts
its deleterious effect also in the last decades of life [36].
Overall, GWASs have proved to be rather disappointing
for identifying genetic determinants of complex traits, that
is, longevity or many age-associated diseases, and established
loci account only for a small proportion of trait heritability.
The lack of robust results can be attributed to different reasons
that include, among others, the need to conduct these studies
on hardly available large cohorts, the phenotypic heterogene-
ity of longevity, the gene-environment interactions, and the
failure to identify both low frequency variants with large
effects and rare variants. One point to take into account
is that each cohort in GWASs could be characterized by
population-specific genetic makeup. This phenomenon has
been suggested by De Benedictis and Franceschi [37] from
the observation that the demographic males/females ratio
among centenarians is consistently different depending on
the geographic origin of individuals. The authors sustain
that this observation provides evidence of the existence of
a genetics characteristic of each population and it makes
less and less impressive the results of GWASs, which include
different populations, even more difficult to interpret. The
advent of next-generation sequencing (NGS) has renewed
interest and hopes of the researchers in the study of the
genetics of longevity, as this technology allows a previously
unattainable systematic discovery of low frequency variants
in thousands of samples. In the context of longevity, NGS
has been applied to assess whether ageing is accompanied
by an accelerated accumulation of somatic DNA mutations
that affects the primary structure of proteins, ultimately
compromising organismal functions [38]. Ye et al. performed
whole genome sequencing of two pairs of monozygotic
twins aged 40 and 100 years old, by using two independent
NGS platforms and validating potentially discordant single-
base substitutions by Sanger, Roche 454, and Ion Torrent
sequencing. Authors found that NGS can detect somatic
single nucleotide substitutions and that getting centenarian is
not accompanied by an increase in the number of detectable
somaticmutations. Furthermore, the authors highlighted that
the low background somatic variation reported within twin
pairs is advantageous if discordant twins are considered for
the identification of disease-related mutations.
Studies carried out so far were unable to discriminate
between two basic assumptions, that is, whether the ability
to reach the extreme limits of human life is due to the pres-
ence of polymorphisms in “longevity genes” that promotes
the achievement of old age or to the absence of harmful
variants [39]. The study of extreme phenotypes has proved
particularly useful to clarify these clinical issues [40]. In the
field of longevity, this approach should include centenarians
and individuals severely affected by age-associated diseases.
Recently, interesting results were reported using this method
to study type 2 diabetes (T2D). 1349 Italians, including 562
T2D patients, 558 unrelated controls, and 229 centenarians,
were genotyped for 31 SNPs mapping within or nearby
genes involved in T2D. rs7903146 in TCF7L2 gene showed a
progressive increase in the frequency of risk genotype (TT)
from centenarians to diabetic patients who developed one or
more complications and the strongest genotypic association
was detected when diabetic patients were compared to
centenarians (𝑃 = 9.066 ∗ 10−7). The use of centenarians
in this kind of studies has proved to be useful to evaluate
the biological relevance of genetic variants emerging from
GWASs. Authors speculate that if a SNP is considered a
statistically significant but “weak” risk factor for the disease
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and it is present at similar frequency in centenarians and in
patients, its biological relevance can be assumed as negligible.
On the contrary, if the frequency of a genetic risk variant is
much higher in patients than in centenarians, it is likely that
this SNP plays a consistent biological role in the pathogenesis
of the disease under study [41]. It is also interesting to note
that the T risk allele and the TT risk genotype were present in
few centenarians, suggesting that they were not able to foster
the T2D phenotype, likely because of being counteracted by
healthy lifestyle.
In addition to centenarians, a widely used model to
investigate longevity consists of long-lived families. Indeed, it
was observed that siblings of centenarians have an increased
relative risk of reaching 100 years, sustaining the existence
of a heritable component of human longevity [42–44]. This
heritable component has been estimated to account for about
25–32% of the observed variation in human population,
with an increasing influence after 60 years of age [42, 45,
46]. To understand whether this heritable component results
mostly from the genetics or from the familial environment,
Schoenmaker et al. [47] proposed to consider spouses of long-
lived subjects as an additional control group. They included
in their analysis 100 families with at least two long-living
siblings and they evaluated standardised mortality ratios,
finding a survival benefit for all siblings of the long-living
participants, for their parents, and for their offspring but not
for their spouses. This result allowed authors to sustain that
the families considered are genetically enriched for extreme
survival and that it is unlikely that environmental factors play
a major causative role in familial longevity. The environment
effect on longevity was studied also by Montesanto et al. [48]
on 202 long-lived families from Calabria. Authors compared
the survival functions of nonagenarians’ siblings to those of
their spouses to estimate the genetic component of longevity,
minimizing the effects of environmental factors. Authors
confirmed that both parents and siblings of the nonagenar-
ians had a significant survival benefit. They also reported for
the first time a gender-effect restricted to males. Indeed, only
male siblings showed a substantial survival advantage and
the presence of a male nonagenarian in a family significantly
decreased the mortality rate throughout lifetime for all the
siblings, suggesting that genetic factors in males strongly
affect the possibility of becoming long-lived. Family studies
of exceptional longevity were performed also to identify rare
genetic variants that cannot be discovered with population-
based studies. One of the largest European projects aimed at
identifying genes involved in healthy ageing, the Genetics of
Healthy Ageing (GEHA) project, was focused on a sophisti-
cated familial model of longevity, that is, nonagenarian sib
pairs, that is, two or more siblings aged 90 years or older
[49, 50]. During GEHA project, 2535 families comprising
5319 nonagenarian siblings were recruited from 15 regions
in 11 European countries. In addition, younger persons
aged 50–75 years were included as unrelated controls but
coming from the same geographical area as the sib pairs. The
comprehensive phenotype description and an estimation of
the survival rate of a subset ofGEHA subjectswere performed
on this exceptional cohort to identify survival predictors
[51]. In particular, some predictors of longevity, includ-
ing sociodemographic, physiological, clinical, and haemato-
chemical parameters, were examined at baseline and 6 years
after the recruitment in 1160 Italian GEHA 90+ siblings. It
was observed that better specific cognitive and functional
parameters (SMMSE, ADL scale, and hand grip strength),
self-reported health, and clinical parameters (haemoglobin,
creatinine, and total cholesterol) in 90+ sib-ships were also
effective survival predictors. Cevenini et al. also suggest that
this combination of the parameters identified in the GEHA
model of healthy ageing is influenced by familiarity/genetics
[51].
A genome-wide linkage analysis on 2118 European nona-
genarian full sibships of the GEHA project was performed
to identify chromosomal regions involved in longevity [52].
By using Illumina HumanLinkage12 Genotyping BeadChip,
four regions (14q11.2, 17q12-q22, 19p13.3-p13.11, and 19q13.11-
q13.32) were identified, together with three loci that were
linked to longevity in a sex-specific manner (8p11.21-q13.1
(men), 15q12-q14 (women), and 19q13.33-q13.41 (women)).
A GWAS performed in the same GEHA 90+ sibships
and controls showed that only rs4420638 was significantly
associated with longevity. As expected by results obtained
in other genome-wide studies, this SNP tags the linkage
disequilibrium block harboring the TOMM40, APOE, and
APOC1 genes. The analysis of APOE𝜀 variants in GEHA
nonagenarians siblings showed that 𝜀4 allele frequency was
significantly lower than that reported for the geographically
matched younger controls (6.8% versus 12.7%). In agreement
with this finding, 𝜀4 allele carriers have about 50% lower
chance to become nonagenarians than the non-𝜀4 carriers
(OR = 0.48, 95%CI = 0.42–0.55).
3. The Mitochondrial Genome
Several theories on ageing process and longevity posed mito-
chondria in a central position.Mitochondria produce the cel-
lular energy through oxidative phosphorylation (OXPHOS)
and many metabolic pathways are located in these organelles
as well as the pathway controlling apoptosis. The two main
mechanisms that link mitochondria to ageing are the muta-
genesis of mitochondrial DNA (mtDNA) and the production
of reactive oxygen species (ROS). The relative contribution
of these two mechanisms and their interplay in the ageing
process are still matter of debate, but a detailed analysis of the
history of these theories is out of the scope of this review and
it is well described elsewhere [53]. However, the more recent
hypothesis states that ROS generation is not per se a cause
of ageing, but rather a consequence of the age-dependent
accumulation of mtDNA damage. Indeed, it is well known
that mtDNAmutations increase with age, and recent findings
show that this increment is likely due to errors in replication
machinery or to unrepaired damage, placing ROS mutagenic
effect in the background. Two studies support this hypothesis:
(i) a study by Kennedy et al. [54] showed that in mice the
mtDNA damage during ageing is not characterized by an
accumulation of transvertions (i.e., the type of mutations
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caused by ROS) but by a higher prevalence of transition; (ii)
the study of Trifunovic et al. [55] showed that defects in the
proofreading function of gamma polymerase (pol𝛾) lead to a
high accumulation of mtDNAmutations and to a consequent
premature ageing of mice that carry these defects.
3.1. Longevity and mtDNA Somatic and Inherited Variabil-
ity. Recent GWASs on age-related diseases [56–59] have
identified some nuclear loci implicated in mitochondrial
bioenergetics (PPAR𝛾, PGC-1𝛼, and UCPs) providing further
support to the hypothesis that mitochondria play a central
role in the ageing process [60–62]. In humans, the processes
influenced by mitochondrial activity and their effects on
degenerative diseases and ageing appear to be modulated
by mtDNA common variants as addressed by many studies
[60, 63–73].
Recently, the association between recurrent or sporadic
mtDNAmutations and longevity has been highlighted by the
results of the GEHA project. In this project the control region
of 3000 samples and the complete mtDNA of 1292 samples
were sequenced including 650 ultranonagenarians (90+) and
a comparable number of controls, enrolled in Denmark,
Finland, Southern Italy, and Greece [74]. A haplogroup
classification and a specific analysis for evaluating the burden
of nonsynonymous mutations in different mtDNA regions
were performed [75]. The results showed that the number
of nonsynonymous mutations in mtDNA genes coding for
subunits of OXPHOS Complexes I, III, and V is different
between 90+ subjects and controls. In particular, the presence
of mutations on complex I may be beneficial for longevity,
while the cooccurrence of mutations on both complexes I
and III or on both I and V might be detrimental to attain
longevity. As haplogroup 𝐽 is characterized by mutations
in complex I genes, this result might explain previous
contrasting findings emerging from association studies on
𝐽 haplogroup and longevity [65, 67, 70, 76–78]. This result
points out the need of complete sequencing of mtDNA in
this type of genetic studies and the inadequacy of studies
based on haplogroup classification. Intriguingly, the analysis
of mtDNA sequences in 90+ and controls has also shown
that many mtDNA mutations associated with a variety of
mitochondrial and degenerative diseases are as frequent in
90+ as in younger controls (e.g., 4336T > C mutation in the
tRNAGln in Alzheimer’s disease), supporting the idea that
the effect of mtDNA mutations is highly influenced by the
individual-specific genetic background (the combination of
nuclear and mitochondrial genome variants), as well as by
stochastic events [68, 79, 80]. In conclusion, a major result
of the GEHA study is that the interaction between mutations
concomitantly occurring on different mtDNA genes can
affect human longevity [74]. Moreover, such an effect of
mtDNA variability on longevity seems to be mainly due to
the cooccurrence of rare, private mutations, which are not
detected by haplogroup analysis.
The complex relationship between mitochondrial genet-
ics and longevity has been further puzzled when somatic
mtDNA variability is considered. Indeed in one cell many
mitochondrial genomes exist and the cooccurrence of
mutated and wild type copies of mtDNAs is named het-
eroplasmy. Many studies [81–83] showed an accumulation
of heteroplasmy during ageing in different tissues (such as
muscle, brain, etc.). Recent findings demonstrated that even
low-frequency heteroplasmic mutations can be inherited
from the mother [84] suggesting a potential role of these
variants as primer to potentiate the effect of somatic muta-
tions that accumulate during ageing [85]. This component
of mtDNA variability is difficult to study, as heteroplasmy
pattern observed in adulthood is a mixture of both inherited
and somatic (acquired) mtDNA mutations. Moreover, the
proportion of mutated mtDNA can vary according to the
tissues and cells considered. Only few studies were able to
establish a link between heteroplasmy and healthy ageing and
longevity [86, 87] and even less studies addressed the role
that these accumulations may have in promoting longevity.
A high incidence of the C150T transition in centenari-
ans’ leukocytes was observed and a remodeling event of
mtDNA replication origin associated with this mutation was
hypothesized. These studies also indicate that the level of
heteroplasmy at position 150 is similar between relatives
and correlates in parent-offspring pairs, thus suggesting a
genetic influence. However previous technologies (such as
DHPLC, pyrosequencing) have not allowed a high-resolution
analysis ofmtDNAvariants occurring at a very low frequency.
The advent of NGS technologies, with their capability for
very high coverage, allows the analysis of mtDNA mutations
at very low frequency with high accuracy [88]. This new
technology applied to powerful models of longevity, such as
centenarians and their offsprings, is expected to answer some
of the open questions in this hot topic.
4. Gut Microbiome
In humans most of the microorganisms reside in the intesti-
nal tract and their role is so central that all these microbes
are considered as an additional organ, characterized by its
own genome [89]. The gut microbial community is predom-
inantly bacterial and the most characterized part inhabits
the distal colon where two bacterial phyla—the Firmicutes
and the Bacteroidetes—constitute more than 90% of the
total community [90]. The relationship between human GM
and the host is highly plastic, with the potential to readily
adapt to changes in diet, life style, and geography, as well
as to the different host ages, defining a process which is
fundamental to maintain host health and homeostasis [91].
This plasticity has been recently highlighted by David and
colleagues [92] that reported the effects on GM composition
of different diets, that is, one based on animal products
and another one based on plant products. Authors observed
that the short-term consumption of these two kinds of
diet alters microbial community structure and bypasses the
interindividual differences in the microbial gene expression.
The composition of the microbiota strongly impacts
on the host health. Indeed, several studies report that the
dysbiosis of the microbiome occurs in different chronic
conditions, including obesity, inflammatory bowel diseases,
and diabetes [93–96].
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Regardless of whether it is a cause or a consequence
of diseases, the GM can actively contribute to diseases
consolidation. Indeed, several studies on disorders show
that a pathologic phenotype can be transmitted from a
diseased animal to a healthy recipient through the graft of the
microbiota and this also applies to complex diseases where
host genetics and environmental factors play a role [97, 98].
The first study that linked microbiota to human ageing dates
back to 1908 whenMetchnikoff postulated that ageing can be
caused by gut microbiota dysbiosis [99].
The age-related changes in gut microbiota are very
controversial and results from recent studies are not always
concordant. In fact the study by Biagi et al. [100], performed
on Italian subjects, showed that Bacteroidetes proportion
remains unchanged in elderly, whereas in a study on Irish
elderly [101] Bacteroidetes strikingly increase and overcome
the Firmicutes. The influence of different cultural habits and
lifestyle in the two populations considered is likely the major
force underlying the observed differences [102], even if a
“study effect” cannot be excluded [103]. This observation is
obviously complicated by a high level of interindividual vari-
ability in the composition of gutmicrobiota.However, studies
agree that old individuals are characterized by a lower GM
diversity [100] and by an enrichment in “pathobionts,” that
is, proinflammatory bacteria that usually are present at low
concentration in healthy individuals [104, 105]. Interestingly,
in centenarians this GM profile has been associated with
inflammaging, a condition that is characterized by a high
level of blood inflammatory markers. A shift in microbial
composition towards an age-related pattern was observed in
inflammatory disorders [106], supporting the proinflamma-
tory nature of an aged-type microbiota. However, the causes
and the effects of a direct association between microbiota
modifications and immunosenescence and inflammaging are
still unclear [107]. Recently, an alteration of GM functional
profile was also observed in extreme ageing. The age-related
trajectory of the human gut microbiome was shown to be
characterized by loss of genes for short chain fatty acid
production—well-known anti-inflammatory GM metabo-
lites [108]—and an overall decrease in the saccharolytic
potential, while proteolytic functions were more abundant
in centenarians’GM than in the intestinal metagenome of
younger adults. Treatments that include prebiotics/probiotics
seem to produce beneficial effects on healthy ageing but an
extensive review of these concepts is outside the purpose
of this review and they are extensively described elsewhere
[107].
5. The Remodeling Theory of Ageing
Human physiology undergoes profound changes from birth
to old age. In the elderly, these changes are mainly the result
of adaptive strategies at the molecular and cellular levels to
compensate the damage accumulation that occurs over time.
A major contribution to these changes is played by the cell
microenvironment. A growing body of evidence supports
the idea that the systemic environment is the repository
of danger signal products and of the whole garbage that
the senescent cells and the impaired tissues produce. Several
studies provide evidence of rejuvenation of aged cells by
exposure to a young systemic environment, suggesting that it
is themicroenvironment towhich the cells are exposed to that
causes/maintains the old phenotype [109–112]. Therefore, the
assumption that a given allele has the same biological effect(s)
in the body (systemic body environment) of young, adult, old,
and very old people is simplistic. Within this perspective, the
remodeling theory was postulated.This theory poses that the
same allele has different effects on the probability of survival
according to age-related physiological conditions (Figure 1),
by modifying gene expression and, as a consequence, the
composition of cell microenvironment which in turn mod-
ifies again gene expression in an amplifying vicious circle,
which eventually is responsible for the systemic age-related
decline. Indeed, as described above, the individual gene-
environment interaction changes with age and a significant
contribution to the remodeling could be provided by the
three genomes interactions.
6. Mitochondrial-Nuclear Crosstalk
More than 90% of the factors required for mitochondrial
function are encoded by the nuclear genome. Coevolution of
mtDNA and nDNA is a crucial process that preserves bio-
logical functionality and cell activities [113]. This is demon-
strated by Kenyon and Moraes who mark the interaction
between nDNA and mtDNA, focusing on species-specific
compatibility between these genomes [114]. In particular,
using xenomitochondrial cybrids they showed that only our
closest relatives, that is, chimpanzee and gorilla, were able to
restore oxidative phosphorylation when placed in a human
nuclear background, whereas distant relatives with a mtDNA
that is more different from an evolutionary point of view,
that is, orangutan and lemur, were not. It is also relevant
to note that the time that leads to incompatibility between
nuclear andmitochondrial genomes could be shorter than the
divergence of species. Indeed, alterations in this equilibrium
could alter cell functionality, leading to an increased disease
susceptibility or pathological processes [115]. mtDNA is
fundamental for energy production in the cell, and both
nuclear and mitochondrial genes are needed to assemble the
mitochondrial translation machinery and to carry out major
processes, such as OXPHOS.
Similar evidences come from studies onDrosophila show-
ing that epistatic interactions can cause incompatibilities that
decrease fitness [116]. In particular, in Drosophila, the cooc-
currence of naturally occurringmutations in amitochondrial
tRNA and in a nuclear-encoded tRNA synthetase that show
little effect on their own severely compromises development
and reproduction. The effect of this interaction affects mito-
chondrial functionality, supporting the hypothesis that the
variable penetrance of mitochondrial DNAmutation is likely
affected by mitochondrial-nuclear interactions [116].
6.1. From the Nucleus to the Mitochondria and Back. Inter-
actions between nDNA and mtDNA products are possi-
ble at many levels such as protein-protein interactions in


























Figure 1: Schematic representation of the remodeling theory.The genetics-environment interactions as a function of age are represented as the
fitness between the screwdrivers (genotype) and screw head shape (cross or cut). In particular, the different gene-environment interaction is
represented by different ratio between the screw head shape. According to the remodeling theory, the interaction between the same genotype
and time-related physiological conditions could result in different fitness, as shown in the three plots (fitness versus age). In particular, the
highest fitness values for each genotype are coloured (red, blue, and green).
the OXPHOS, protein-RNA interactions in the mitochon-
drial ribosome, or nuclear factors-mtDNA recognition sites
interactions in transcription and replication processes [115,
117, 118]. The interaction between these two genomes is
bidirectional, meaning that there are both a flow of infor-
mation from the nucleus toward the mitochondria and a
mitochondrial retrograde signaling pathway.
Regarding the first type of communication (from the
nucleus to the mitochondria), the nDNA encodes for all
potential factors that regulate mtDNA replication, transcrip-
tion, and processing, including mtDNA polymerase (pol𝛾).
Nevertheless, nDNA encodes not only regulatory factors,
but also structural proteins that constitute the respiratory
multimeric protein complexes, as well as some noncoding
RNAs that are imported subsequently into the mitochondria.
Complex I contains 7 mtDNA gene products and at least 25
nDNA gene products, complex II contains no mtDNA gene
products and 4 nDNAgene products, complex III ismade of 1
mtDNA gene product and 10 nDNA gene products, complex
IV contains 3 mtDNA gene products and 10 nDNA gene
products, and complex V contains 2 mtDNA gene products
and 11 nDNA gene products [119]. Regarding the nucleus-
encoded RNAs, many import mechanisms exist but are still
not fully understood [120].
Communication from the mitochondria to the nucleus
involves metabolic signals (including ROS) but this field of
research suffers from the lack of human studies. However,
recent studies in C. elegans demonstrated that neuronal cells
that experiencedmitochondrial stress (i.e., electron transport
chain (ETC) impairment) produce a signal that is transmitted
from the mitochondria to the nucleus. Then, these cells
produce other extracellular signals (called “mitokines”) that
are able to induce a stress response (mitochondrial unfolded
protein response) in the intestine, without altering the ETC
functionality in intestinal cells. As it was observed that this
mechanism extends lifespan, the authors speculate that a
diffusible molecule released from one tissue might spread a
sort of “longevity signal” to other tissues [121, 122].
The mechanisms that regulate the communication
between these two genomes are not completely elucidated.
To date, it is well known that the balance of the crosstalk
between the nDNA and the mtDNA is essential for cellular
homeostasis and events that perturb this delicate equilibrium
increase the vulnerability of the cell and, thereby, the rate of
ageing. Regarding the ageing process, a particular attention
should be devoted to SNPs located in nDNA or in mtDNA
that may affect the communication between these genomes.
An interesting papers by Bertolin et al. [123] focuses on
the role of TOMM machinery (a multiprotein complex
responsible for importing most of mitochondrial proteins)
in the mitochondrial clearance. Under normal conditions,
damaged mitochondria are removed via autophagy but
during ageing autophagy declines [124, 125], leading to
accumulation of dysfunctional mitochondria. Bertolin and
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colleagues demonstrated that the degradation of the core
structure of the TOMM complex is crucial in mitochondrial
clearance and that mutations in PARK2, a cytosolic E3
ubiquitin-protein ligase recruited for proteasomal-mediated
degradation of outer mitochondrial membrane, significantly
affect the interaction with TOMM70A and TOMM40.
These results let us hypothesize that also SNPs located in
genes of the TOMM machinery could be involved in the
effectiveness of autophagic mitochondrial clearance. From
this point of view, rs2075650 in TOMM40 that is associated
to longevity, as previously described, could affect the relative
configuration of the partners of TOMM complex, resulting
in a more efficient clearance of damaged mitochondria.
In this context, further studies are needed to elucidate the
interactions between mtDNA and nuclear gene variants
assessing their association with longevity in human.
The study of epistatic interactions represents a challenge
[126] that is gradually becoming more achievable with the
availability of NGS techniques. Indeed, the significant drop
in costs and time commitment required to obtain a complete
mtDNA sequence caused a burst in the number of available
samples in both private and public databases [127]. It is
noteworthy that about 22% of the whole database of the com-
plete human mtDNA sequences was deposited in the last 12
months.The nDNA andmtDNA interactions could represent
a critical issue when considered in the context of age-related
heteroplasmy accumulations. Indeed, locally heteroplasmic
mutations that alter this complex interaction can spread with
age and impair cellular and tissues homeostasis.
7. Gut Microbiota-Host Genes Crosstalk
and Role of the Diet
The three-way interaction between human genetics, environ-
ment, and microbiota fundamentally shaped the biological
history of modern human populations and continues to
affect healthy globally. The disruption of this interaction and
stability bymodifying one ormore of these three components
may be a trigger for the development of diseases.
A recent paper tried to determine to what extent the
gut microbiota is determined by the host or by environ-
mental factors, such as diet. This study demonstrated that
the composition of gut microbiota among great ape species
is phylogenetically conserved and pattern of relationship
inferred from the analysis of the microbial communities
was very similar to that inferred from host mitochondrial
DNA, suggesting that host genome is a fundamental factor in
determiningmicrobial composition [128]. Ley and colleagues
[129] suggested that both diet and phylogeny have driven
the coevolution of mammalians and their gut microbiome.
While, at large taxonomic scale, “diet” appears to be the
major driving factor, at lower taxonomic scale, “phylogeny”
well reflects microbiome composition. However, in certain
circumstances, a highly specialized diet can override the
phylogenetic inertia, resulting in an adaptive microbiome
convergence of phylogenetically distant hosts that share a
well-defined dietary specialization [130].
The role of human genetics in the assembly of the
human intestinal microbiota is still controversial. Turnbaugh
et al. [93] reported that monozygotic and dizygotic twins
showed a comparable degree of similarity between their
intestinal microbial communities. Since family members had
a more similar intestinal microbiota profile than unrelated
individuals, the authors concluded that the host genetics is
secondary to environmental exposures in shaping the gut
microbial ecology. However, another fingerprinting study of
monozygotic and dizygotic twins showed a slightly reduced
microbiota similarity profile in dizygotic twins [131].
A recent study in mice investigated how environmental
stimuli and host genetic factors combine together to shape
microbiota composition. In particular, this is the first study
that tries to estimate the effects of maternal environment and
host genetics.The results showed 18 host quantitative trait loci
(QTL) in linkage with specific microbial taxa. In particular
some of these loci affect species composition, others affect
taxa, and others exert a pleiotropic effect.The authors suggest
that the core measurable microbiota can be used in GWASs
in humans [132].
Moreover, there is a clear evidence that host-microbe
crosstalk involves the immune system, and in particular the
gut-associated lymphoid tissue (GALT) likely developed to
oversee the interaction between bacteria that live close to the
intestinal mucosal surfaces [133]. In this process, enterocytes
exert a very crucial role steering GALT toward tolerance or
responsiveness, depending on the perceived degree of treats
[134].
From an evolutionary perspective, the GALT-GM immu-
nological crosstalk and the related tolerance of the immune
system to the gut microbes have been a basal trait in
mammalian evolution. Thus, the coevolutionary trajectories
between mammals and their GM have been shaped by
adaptive changes in the host genes that play a primary role
in the crosstalk with the harbored microbial communities.
GWASs identified genes of both innate and adaptive
immunity as relevant for inflammatory diseases, and inter-
estingly several of these genes have been shown to have a role
in shaping the gut microbial community. Genetic variants
of several nuclear genes for components of immune system
showed to have an impact on the composition of the gut
microbiome. Mediterranean Fever (MEFV) gene encodes a
protein called pyrin/marenostrin that controls inflammation
by interacting with the cytoskeleton in white blood cells and
that, when mutated, leads to an autoinflammatory disorder
called “familial Mediterranean fever” [135]. Khachatryan
et al. [136] demonstrated that mutations in MEFV gene
are associated with a shift in the Bacteroidetes, Firmicutes,
and Proteobacteria phyla and that patients with familial
Mediterranean fever have a lowermicrobial diversity.MYD88
gene is involved in communications between sensors of
microbial products during inflammatory responses and loss
of MYD88 compromises the innate immune response to
pathogens [137]. The microbiota from MYD88-deficient and
wild-type mice was compared and it was found that three
bacterial families (Lactobacillaceae, Rikenellaceae, and Por-
phyromonadaceae) differ in their relative abundance [138].
Studies on IgA locus were performed on both mice and
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humans. It was reported that mice deficient in IgA harbor
an increase abundance of Candidatus Savagella [139]; fur-
thermore, a decrease in proportion of IgA-coated bacteria in
humans was associated with weight loss [140]. Other genes
having roles in metabolism have been identified. APOA1 is
the major component of high density lipoprotein in plasma
and SNPs in APOA1 gene have been associated with the risk
of cardiovascular diseases [141] and with T2D [142]. Zhang
et al. observed that the microbiota of APOA1-deficient mice
has a different community structure in comparison with that
of wild-type mice [143].
However, despite this clear coevolution between gut
microbiota and host genomes, external stimuli are likely to
play a crucial role in determining interindividual variability
[144]. Diet is one of the external stimulus able to influence
microbial compositions, and its effect on the microbiota is
already reviewed elsewhere [145]. It has been demonstrated
that a change from low in fat and rich in polysaccharide
diet to a western diet, high in saturated and unsaturated fats,
alters the microbial profile [146] and a high fat diet changes
drastically the ratio between Bacteroidetes and Firmicutes.
Furthermore, a recent study explores the intestinal micro-
biota from European children (characterized by western
diet) and from children born in an African rural village
in Burkina Faso (characterized by a fiber rich diet). The
results suggest that consumption of sugar, animal fat, and
calorie-dense foods in industrialized countries is rapidly
limiting the adaptive potential of the microbiota by reducing
functionality itself [147]. However, little is known regarding
the relationship between environment and nuclear genetics
in shaping this biodiversity. Studies by Franceschi and by
other research groups clearly show that the ecology of the gut
microbiota changes with age [100, 101, 104–108]. However, it
is yet unclear how the drivers of this change combine with
inflammaging, diet/environment, and genetic background.
In any case it can be predicted that the age-related changes in
the GM can stress and amplify the different genetic makeup
of the host.
8. Conclusions: The Omic Challenge
This overview clearly shows that the knowledge of the genet-
ics of human ageing relies on three pillars, that is, nuclear
genetics, mitochondria genetics, and microbiome genetics.
Until now this research field has suffered the fact that these
three genetic domains have been studied separately, and it
is urgent to set up investigations capable of analyzing these
three genomics altogether. If these considerations are correct,
the phenotypic characterization of the people/models used
in genetic studies of ageing and longevity becomes critical,
particularly regarding the lack of information of GM in most
of the studies. The poor knowledge of GM genetics is critical
because it is closely related to anthropological variables such
as nutrition and diet. Similar considerations must be applied
to the fact that mitochondrial genetics is not considered in
GWASs, as the mitochondrial genome is closely related to
human population evolution that is in turn molded by envi-
ronmental adaptation to climate and diet. Finally, all the three
genetic components of longevity change with age, and this is
particularly evident in GM and mtDNA but it also applies to
more subtle, but quantitatively more important, mutations in
nDNA. Overall, the emerging scenario is that of a continuous
and dynamic interaction between the different components
of the genetics of human longevity that was unpredictable
until recently and is currently largely unexplored.
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